While some studies reported increased circulating classical (CD14+CD16-) and decreased intermediate (CD14+CD16+) and non-classical monocyte frequencies (CD14-CD16+) in PD, others failed to find statistically significant differences in PD [126-129]. Here, CD14 is linked to Parkinson disease.